Interventional cardiologists who have evolved the techniques for these difficult procedures need innovative, enabling devices they can absolutely count on. Guideliner (Teleflex), Guidezilla (Boston Scientific), Guidion (IMDS), or Telescope (Medtronic) guide catheter extension (Section 30.3) is advanced into the.
Teleflex Medical Director Christopher Buller, MD, added, “The CTO-PCI IDE study confirmed the safety and effectiveness of a range of these products in very complex CTO cases. “Given the challenging patient population, the high technical success rate in this most demanding PCI environment is particularly notable.” “Considering the complexity of both anatomy and procedural strategy in this study, the very favorable success achieved underscores the need for an ‘interventional toolbox’ that features an array of enabling device technologies that include guidewires, guide catheter extensions and microcatheters,” commented Dr. Kandzari, MD, who is Director, Interventional Cardiology and Chief of the Piedmont Heart Institute and Cardiovascular Service Line in Atlanta, Georgia, was one of the study’s principal investigators. In 2009, the GuideLiner® Catheter revolutionized the concept of guide extension, creating new possibilities in interventional cardiology. Teleflex would like to track your usage on our site, and use that data to. Teleflex stated that in this very complicated cohort, technical success (defined as successful guidewire recanalization) was achieved in 93.3% of cases, and procedural success defined as freedom from major adverse cardiovascular events was achieved in > 75% of cases.ĭavid E. The GuideLiner Coast Catheter provides everything that helped the GuideLiner. These products were evaluated as part of the CTO-PCI study, a peer-reviewed, prospective, single-arm investigational device exemption (IDE) study that enrolled 150 patients at 13 investigational centers across the United States. In 2009, the GuideLiner Catheter revolutionised the concept of guide extension, creating new possibilities.
February 23, 2022-Teleflex Incorporated announced that the FDA has cleared an expanded indication for its specialty catheters and coronary guidewires for use in crossing chronic total occlusion (CTO) during percutaneous coronary intervention (PCI).Īccording to the company, devices receiving the expanded indication include the Teleflex GuideLiner V3 catheter, TrapLiner catheter, Turnpike catheters, Spectre guidewire, Raider guidewire, Bandit guidewire, Warrior guidewire, and R350 guidewire. Guide extension catheter with half-pipe technology. Teleflex: GuideLiner V3 Catheter 5, 5.5, 6, 7, 8: 150: 0.056 (5 F), 0.066, 0.070 (6 F), 0.078 (7 F), 0.088 (8 F) Features a half-pipe design for seamless collar transition this rapid-exchange, coaxial mother-and-child guide extension is delivered through standard guide catheters, resulting in an ID approximately one F size.
0 kommentar(er)
